ARTN and Fabry disease: We suggest that the interrogation of GDNF pathways, particularly artemin-GFRα3 signaling, in preclinical models of FD may provide insights into the role of the associated receptors and ligands, as well as inflammatory pain mechanisms, in FD/MAS [18].